My bookmarksSign up free
Source

2014/396/EU: Commission Implementing Decision of 24 June 2014 authorising the placing on the market of UV-treated baker's yeast ( Saccharomyces cerevisiae ) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2014) 4114)

2014/396/EU: Commission Implementing Decision of 24 June 2014 authorising the placing on the market of UV-treated baker's yeast ( Saccharomyces cerevisiae ) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2014) 4114)

Regulation (EC) No 258/97 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

UV-treated baker's yeast as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses defined and at the maximum levels established in Annex II without prejudice to Directive 2002/46/EC and Regulation (EC) No 1925/2006.

Article 2

Open ↗

The designation of UV-treated baker's yeast authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘vitamin D yeast’ or ‘vitamin D 2 yeast’.

Article 3

Open ↗

This Decision is addressed to Lallemand SAS, 19 Rue des Briquetiers BP59, 31702 Blagnac Cedex, France.

Supplementary provisions

SPECIFICATION OF UV-TREATED BAKER'S YEAST

ANNEX ISupplementary provisions

Open ↗

ANNEX I SPECIFICATION OF UV-TREATED BAKER'S YEAST Definition : Baker's yeast ( Saccharomyces cerevisiae ) is treated with ultraviolet light to induce the conversion of ergosterol to vitamin D 2 (ergocalciferol). Vitamin D 2 content in the yeast concentrate varies between 1 800 000-3 500 000 IU vitamin D/100 g (450-875 μg/g). Description : Tan-coloured, free-flowing granules Vitamin D 2 : Chemical name (5Z,7E,22E)-3S-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol Synonym Ergocalciferol CAS No 50-14-6 Molecular weight 396,65 g/mol Microbiological criteria of the yeast concentrate : Coliforms Not more than 1 000 /g Escherichia coli Not more than 10/g Salmonella spp. Absent in 25 g

AUTHORISED USES OF UV-TREATED BAKER'S YEAST

ANNEX IISupplementary provisions

Open ↗

ANNEX II AUTHORISED USES OF UV-TREATED BAKER'S YEAST Food category Maximum use level Yeast-leavened breads and rolls 5 μg of vitamin D 2 /100 g final product Yeast-leavened fine bakery wares 5 μg of vitamin D 2 /100 g final product Food supplements 5 μg of vitamin D 2 /day

Other acts of the same type
Political and Security Committee Decision (CFSP) 2025/2010 of 25 September 2025 on the appointment of the EU Mission Force Commander of the European Union CSDP Military Training Mission in the Central African Republic (EUTM RCA) and repealing Decision (CFSP) 2024/2192 (EUTM RCA/1/2025)Commission Implementing Decision (EU) 2025/1939 of 24 September 2025 amending Implementing Decision (EU) 2021/1402 as regards harmonised standards for thermal energy meters drafted in support of Directive 2014/32/EU of the European Parliament and of the CouncilDecision (EU) 2025/1970 of the European Central Bank of 23 September 2025 amending Decision (EU) 2022/911 concerning the terms and conditions of TARGET-ECB (ECB/2022/22) (ECB/2025/32)Decision (EU) 2025/2015 of the European Central Bank of 23 September 2025 on transitional provisions for the application of minimum reserves by the European Central Bank following the introduction of the euro in Bulgaria (ECB/2025/33)Commission Implementing Decision (EU) 2025/1898 of 22 September 2025 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP51291 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2025) 6319)Commission Implementing Decision (EU) 2025/1900 of 22 September 2025 establishing the annual programme of controls for 2026 to be carried out by Commission experts in the Member States to verify the application of Union agri-food chain legislationCommission Implementing Decision (EU) 2025/1931 of 22 September 2025 amending Implementing Decision (EU) 2025/1708 concerning certain emergency measures relating to infection with lumpy skin disease virus in France (notified under document C(2025) 6528)Council Decision (CFSP) 2025/1932 of 22 September 2025 amending Decision (CFSP) 2023/2135 concerning restrictive measures in view of activities undermining the stability and political transition of SudanCouncil Decision (CFSP) 2025/1935 of 22 September 2025 amending Decision 2012/285/CFSP concerning restrictive measures in view of the situation in Guinea-BissauCouncil Implementing Decision (CFSP) 2025/1936 of 22 September 2025 implementing Decision 2013/255/CFSP concerning restrictive measures in view of the situation in SyriaCommission Implementing Decision (EU) 2025/1938 of 22 September 2025 amending Implementing Decision (EU) 2025/1582 concerning certain emergency measures relating to infection with lumpy skin disease virus in Italy (notified under document C(2025) 6529)Council Decision (CFSP) 2025/1941 of 22 September 2025 amending Decision (CFSP) 2015/1763 concerning restrictive measures in view of the situation in Burundi

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next